Particulars |
Company Name |
Glaxosmithkline Pharmaceuticals Ltd |
Year End |
202303 |
Full Year |
Equity (Rs Cr.) |
169.41 |
B.V. Rs |
91.40 |
Sales Rs Cr. |
3,216.34 |
NP Rs Cr. |
586.70 |
NP Var% |
-65.00 |
Div% |
320.00 |
CPS Rs |
38.50 |
EPS Rs |
34.60 |
Traded Value(Rs Lakhs) |
183.53 |
52 Week High |
2,650.00 |
52 Week Low |
1,242.00 |
Price BSE |
2,094.00 |
Price NSE |
2,095.00 |
Market Capital(Rs Cr.) |
35,471.08 |
P/C Ratio |
54.40 |
P/E Ratio |
60.50 |
Price Vs.BV |
22.91 |
|
Latest Quarter |
Year End |
202312 |
Sales Rs Cr. |
804.98 |
NP Rs Cr. |
177.48 |
NP Var % |
3.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
3,234.97 |
OPM |
27.59 |
NP |
412.71 |
NP Var% |
46.73 |
EPS |
37.52 |
PE |
55.81 |
|
|